• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
What can we expect from the latest COVID wave?

What can we expect from the latest COVID wave?

How long is the new wave likely to last? As case numbers continue to rise, UNSW academic James Wood looks at the most probable outcomes.


Decline in Australia’s COVID vaccine donations as wastage soars

Decline in Australia’s COVID vaccine donations as wastage soars

Untold numbers of Australian COVID-19 vaccines are ending up in the bin, when they could be going into the arms of the world’s most vulnerable.


Research shows BRCA-related cancers not a ‘female-only thing’

Research shows BRCA-related cancers not a ‘female-only thing’

Males who carry a fault in BRCA1 or BRCA2 genes may be at greater risk of prostate, breast, stomach and pancreatic cancers, a new study suggests.


New point-of-care test for COVID-19 could assess need for booster

New point-of-care test for COVID-19 could assess need for booster

Developed by Australian scientists, experts say the test could be the key to staying one step ahead of COVID-19 variants.


What is the AY.4.2 COVID variant under investigation in the UK?

What is the AY.4.2 COVID variant under investigation in the UK?

The potentially more transmissible strain is descended from the main Delta variant and has already been identified in Australia.


Study suggests Delta more than doubles death risk

Study suggests Delta more than doubles death risk

A new peer-reviewed article backs findings of much higher virulence in the Delta variant and its harsher impact on younger people compared to previous strains.


How advanced are COVID booster vaccines?

How advanced are COVID booster vaccines?

With ATAGI flagging that third doses and booster shots could soon be used to further protect against COVID, newsGP assesses preliminary results from Moderna and Pfizer’s ongoing clinical trials.


Are vaccines alone enough to avoid COVID mortality?

Are vaccines alone enough to avoid COVID mortality?

The emergence of highly infectious variants could see the risk of death remain at high levels, according to new modelling that has been described by some as ‘pessimistic’.


Evidence suggests AstraZeneca and Pfizer are equally effective

Evidence suggests AstraZeneca and Pfizer are equally effective

Experts say the research is reassuring, and indicates that both COVID vaccines offer a pathway to Australia reaching a high level of immunity.


Peer review confirms Novavax effective against emerging variant

Peer review confirms Novavax effective against emerging variant

While the vaccine’s efficacy rate is significantly lower against the South African variant than the original strain, there are other factors to consider in a real-world context.


  • Previous
  • 1
  • 2
  • Next
Pages: 1 of 2
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807